Skip to main content

Table 4 Schedule in relation to YF17D vaccination

From: The role of pre-existing cross-reactive antibodies in determining the efficacy of vaccination in humans: study protocol for a randomized controlled trial

 

Visit 4

Visit 5 - 1 day after

Visit 6 - 3 days after (±1 day)

Visit 7 - 1 week after (±2 days)

Visit 8 - 1 month after (±5 days)

Visit 9 - 1 year after (±7 days)

 

Pre-vaccination (any time before dosing)

Post-vaccination (1 hour)

Physical examination

 

×

×

×

×

×

×

Vital signsa

×

×

×

×

×

×

×

Assessment for clinical symptoms (local and general symptoms)

 

×

×

×

×

×

 

Blood sampling in relation to YF17D vaccination

×

 

×

×

×

×

×

Adverse eventsb

×

 

×

×

×

×

×

Concomitant medications

×

 

×

×

×

×

×

  1. aVital signs include temperature (oral and tympanic allowed), blood pressure, pulse rate, and respiratory rate. bClinical Trial Certificate Adverse Events version 4.0 will be used for grading. YF, yellow fever.